Corton Capital Inc. Acquires New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Corton Capital Inc. purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 10,806 shares of the company's stock, valued at approximately $251,000.

Other institutional investors have also modified their holdings of the company. Brevan Howard Capital Management LP lifted its holdings in Option Care Health by 218.4% in the 4th quarter. Brevan Howard Capital Management LP now owns 26,338 shares of the company's stock valued at $611,000 after acquiring an additional 18,067 shares during the last quarter. Balyasny Asset Management L.P. raised its position in Option Care Health by 338.0% during the fourth quarter. Balyasny Asset Management L.P. now owns 168,082 shares of the company's stock valued at $3,900,000 after acquiring an additional 129,708 shares in the last quarter. BNP Paribas Financial Markets acquired a new position in Option Care Health during the fourth quarter valued at approximately $1,311,000. Ameriprise Financial Inc. grew its holdings in Option Care Health by 4.3% during the fourth quarter. Ameriprise Financial Inc. now owns 193,702 shares of the company's stock valued at $4,494,000 after purchasing an additional 7,922 shares during the last quarter. Finally, Algert Global LLC grew its stake in shares of Option Care Health by 29.3% in the fourth quarter. Algert Global LLC now owns 248,142 shares of the company's stock worth $5,757,000 after acquiring an additional 56,235 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

NASDAQ:OPCH traded down $0.07 during trading hours on Tuesday, hitting $31.79. The company's stock had a trading volume of 656,701 shares, compared to its average volume of 1,845,771. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a market capitalization of $5.21 billion, a P/E ratio of 26.71, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a fifty day simple moving average of $33.19 and a 200-day simple moving average of $28.91.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the company earned $0.26 earnings per share. The firm's revenue was up 16.3% compared to the same quarter last year. On average, analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on OPCH. Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. JMP Securities restated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.